Leadiant Biosciences, Inc. (United States) has no DMF, CEP or site registration linked in our records. 5 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Leadiant Biosciences, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/leadiant-biosciences-inc

Overview

Leadiant Biosciences, Inc. is a pharmaceutical company focused on developing and delivering therapies that address the unmet needs of patients with rare diseases. It operates as a subsidiary of Leadiant Biosciences S.p.A., which is based in Italy.

Therapeutic areas

FDA compliance signals

5 FDA enforcement records linked to this company.

  • recall — Class II2023-02-22

    Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.

  • 4832021-07-08

    Interval

  • recall — Class III2020-10-21

    Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.

  • recall — Class III2018-04-25

    Subpotent drug: Out of specification for an active ingredient cysteamine hydrochloride.

  • recall — Class III2018-03-07

    Subpotent Drug: Out of specification for an active ingredient cysteamine hydrochloride.

For suppliers

Is this Leadiant Biosciences, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.